Clinical Trial

A Phase 3, Randomized, Multicenter, Open-Label, Parallel-Group Clinical Study Comparing the Safety and Efficacy of MYL-1601D with NovoLog® in Type 1 Diabetes Mellitus Patients Protocol MYL-1601D-3001)

Study Status:

Contact Information:

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose

A study for patients with Type 1 Diabetes Mellitus that compares the safety and efficacy of MYL-1601D with NovoLog®


Principal Investigator Marcel B. Twahirwa, MD
Sponsor Mylan GmbH/Switzerland
Type of Trial Interventional